[Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis].
The VEGF -1154G/A polymorphism, but not the -460C/T polymorphism, was associated with an increased risk of endometriosis and adenomyosis, with the GG genotype conferring the highest risk.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study investigated whether single nucleotide polymorphisms in the VEGF gene promoter (-460C/T and -1154G/A) are associated with susceptibility to endometriosis and adenomyosis by genotyping 344 endometriosis patients and 360 controls, and 174 adenomyosis patients and 199 controls using PCR-RFLP. No significant differences were found between either patient group and controls for VEGF -460C/T genotype or allele frequencies (all P>0.05). In contrast, VEGF -1154G/A showed significant differences in both conditions: the GG genotype was associated with higher risk compared with GA+AA (endometriosis OR=1.43, 95% CI 1.05–1.96; adenomyosis OR=1.95, 95% CI 1.26–3.03), and allele frequencies also differed (all P<0.05). The paper does not explicitly discuss limitations in the abstract; it is limited to the two promoter SNPs and the studied sample set. This paper is centrally about endometriosis and adenomyosis — specifically, it tests VEGF promoter -1154G/A and -460C/T polymorphisms for genetic risk association.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (11)
- W131977089 via openalex
- W2099776182 via openalex
- W2102482461 via openalex
- W2103610125 via openalex
- W2142340186 via openalex
- W2154358347 via openalex
- W2156285412 via openalex
- W2165590827 via openalex
- W2209846658 via openalex
- W2414336501 via openalex
- W3021664385 via openalex
Cited by (11)
- Adenomyosis: Mechanisms and Pathogenesis 2020
- The impact of vascular endothelial growth factor single nucleotide polymorphisms in the development and severity of endometriosis: A systematic review of the literature 2020
- Epidemiological aspects of the outcomes from the treatment of endometriosis: Experience from two different geographical areas 2019
- Co‑existence of benign gynecological tumors with endometriosis in a group of 1,000 women 2017
- Role of vascular endothelial growth factor polymorphisms (-2578C > A, -460 T > C, -1154G > A, +405G > C and +936C > T) in endometriosis: a case–control study with Brazilians 2014
- Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies 2013
- Vascular endothelial growth factor gene polymorphisms and endometriosis risk: a meta-analysis 2012
- Insights into Assessing the Genetics of Endometriosis 2012
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
- Polimorfismos genéticos e endometriose: A contribuição dos genes que regulam a função vascular e o remodelamento de tecidos 2012
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:11.755070+00:00